Phase 2 Double-Blind Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil.
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2010
At a glance
- Drugs PRX 3140 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors EPIX Pharmaceuticals
- 05 Feb 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 21 May 2008 Patient numbers amended from 400 to 420 as reported by ClinicalTrials.gov.
- 21 May 2008 The expected completion date has been identified as Jan 2010 as reported by ClinicalTrials.gov.